Skip to main content

Table 2 Medical and treatment characteristics

From: Adult ADHD patient experiences of impairment, service provision and clinical management in England: a qualitative study

 

Diagnosed in adulthood (n = 15) N (%)

Diagnosed in childhood (n = 15) N (%)

Current Medication use

  

Using Medication

13 (87)

12 (80)

Discontinued Medication*

2 (13)

3 (20)

Current Medication Type

  

Methylphenidate

10 (77)

11 (92)

Atomoxetine

1 (8)

1 (8)

Dexamphetamine

2 (15)

0 (0)

Duration Since Diagnosis

  

< 1 year

1 (7)

0 (0)

1-5 years

4 (27)

2 (13)

6-10 years

7 (47)

4 (27)

11-15 years

2 (13)

8 (53)

16+ years

1 (7)

1 (7)

Duration on ADHD Medication** (n = 24)

  

< 1 year

5 (42)

3 (25)

1-5 years

4 (33)

2 (17)

6-10 years

2 (17)

5 (42)

11-15 years

0 (0)

2 (17)

16+ years

1 (8)

0 (0)

  1. *Discontinued for a period of 6 months or longer.
  2. **missing data for 6 participants.